Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.

Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53.

Ruvim Izickson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older.

Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research.

Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients.

Daniel Altmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes.

Comment author Michael Kreuter discusses a series of papers published in the Lancet and the Lancet Respiratory Medicine on interstitial lung disease.

Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.

Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries.